FDA Approves First Breakthrough Therapy – Genentech’s Gazyva(TM) Posted on Sun/3/NovemberSun/3/November by AZBio FDA Approves Gazyva™ (Obinutuzumab) for People With Previously Untreated Chronic Lymphocytic Leukemia (CLL)Continue reading→